Attached files
Exhibit
99.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Amarillo Biosciences, Inc. on
Form 10-K for the period ended December 31, 2019 as filed with the
Securities and Exchange Commission on the date hereof (the
“Report”), the undersigned, in the capacity and on the
date indicated below, hereby certifies pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of his
knowledge:
1.
The Report fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2.
The information
contained in the Report fairly presents, in all material respects,
the financial condition and results of operation of the
Company.
Date: March 30, 2021
|
|
/s/ Stephen T.
Chen
|
|
|
Stephen T. Chen, Chairman of the Board,
Chief Executive Officer and Chief Financial Officer
|
F-6